Search by Drug Name or NDC
NDC 17478-0542-25 Adenosine 3 mg/mL Details
Adenosine 3 mg/mL
Adenosine is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Akorn. The primary component is ADENOSINE.
Product Information
| NDC | 17478-0542 |
|---|---|
| Product ID | 17478-542_f0e6a3b7-5974-47e8-96d3-cb2d2b0cd075 |
| Associated GPIs | 35500010002015 |
| GCN Sequence Number | 013630 |
| GCN Sequence Number Description | adenosine VIAL 3 MG/ML INTRAVEN |
| HIC3 | A2A |
| HIC3 Description | ANTIARRHYTHMICS |
| GCN | 35350 |
| HICL Sequence Number | 003734 |
| HICL Sequence Number Description | ADENOSINE |
| Brand/Generic | Generic |
| Proprietary Name | Adenosine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Adenosine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 3 |
| Active Ingredient Units | mg/mL |
| Substance Name | ADENOSINE |
| Labeler Name | Akorn |
| Pharmaceutical Class | Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA078076 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 17478-0542-25 (17478054225)
| NDC Package Code | 17478-542-25 |
|---|---|
| Billing NDC | 17478054225 |
| Package | 25 VIAL in 1 CARTON (17478-542-25) / 2 mL in 1 VIAL |
| Marketing Start Date | 2011-03-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |